Humana Inc.
Humana Inc. is an American managed healthcare company focused primarily on Medicare Advantage, the privately administered alternative to traditional Medicare that now covers more than half of eligible beneficiaries, generating $129.7 billion in revenue in fiscal 2025. Through its Insurance segment, Humana provides health coverage to approximately 15 million medical members, with individual Medicare Advantage representing roughly 70% of consolidated revenue; through CenterWell, it delivers pharmacy, primary care, and home health services that both serve its own members and generate external revenue.
This is a story about a company absorbing the largest revenue headwind in its history — a roughly $3.5 billion Stars-driven funding reduction in 2026 — while simultaneously pursuing one of the most aggressive growth strategies in the managed care sector. Humana added approximately one million new individual Medicare Advantage members during the 2026 Annual Enrollment Period, even as competitors like Elevance and Centene were shedding unprofitable books to protect margins. The trade is explicit: sacrifice near-term earnings for market share, betting that the lifetime value of those new members, combined with a multi-year cost transformation program and a Stars recovery by payment year 2028, will produce sustainably higher earnings power on the other side.
The file turns on a single question: whether the $3.5 billion Stars headwind represents a temporary earnings trough that a fundamentally sound Medicare Advantage franchise will grow through, or an early signal that the structural economics of the business — the gap between medical cost trend and government funding, the concentration risk in a single federal program, and the difficulty of sustaining quality scores at scale — have deteriorated beyond what management's transformation program can repair within a reasonable timeframe.
Full report locked
You are viewing the public summary. The full report — business breakdown, key debates, financials, scenarios, charts and risks — is available to password holders.
Log in to read the full report →Invitation-only proof of concept. Not investment advice.